Correction: Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells

Cell Death Discov. 2022 Nov 30;8(1):472. doi: 10.1038/s41420-022-01275-z.

Twana Alkasalias^#^{1

2}, Juan Zhang^#¹, Harsha Madapura^{1

3}, Basile Dalarun¹, Oscar Bedoya Reina¹, Rolf Lewensohn^{4

5}, Kristina Viktorsson⁴, Abbas Salihi^{1

6}, Suhas Darekar^#^{7

8}, Sonia Laín^#^{9

10}

¹ Department of Microbiology, Tumor and Cell Biology (MTC), Biomedicum, Karolinska Institutet, Stockholm, Sweden.
² General Directorate of Scientific Research Center, Salahaddin University-Erbil, Erbil, Kurdistan Region, Iraq.
³ Science for Life Laboratory, Stockholm, Sweden.
⁴ Department of Oncology-Pathology, BioClinicum, Karolinska Institutet, Stockholm, Sweden.
⁵ Theme Cancer, Patient Area Head and Neck, Lung and Skin, Karolinska University Hospital, Stockholm, Sweden.
⁶ Department of Biology, College of Science, Salahaddin University‑Erbil, Erbil, Kurdistan Region, Iraq.
⁷ Department of Microbiology, Tumor and Cell Biology (MTC), Biomedicum, Karolinska Institutet, Stockholm, Sweden. suhas.darekar@ki.se.
⁸ Science for Life Laboratory, Stockholm, Sweden. suhas.darekar@ki.se.
⁹ Department of Microbiology, Tumor and Cell Biology (MTC), Biomedicum, Karolinska Institutet, Stockholm, Sweden. sonia.lain@ki.se.
¹⁰ Science for Life Laboratory, Stockholm, Sweden. sonia.lain@ki.se.

^# Contributed equally.

No abstract available

Publication types